Evidence map›Paper›PMID 16286645›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2005

Calcineurin regulates bone formation by the osteoblast.

Li Sun, Harry C Blair, Yuanzhen Peng, Neeha Zaidi, Olugbenga A Adebanjo, Xue Bin Wu, Xing Yao Wu, Jameel Iqbal, Solomon Epstein, Etsuko Abe and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Mechanosensitive ion channels as novel targets in osteoporosis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Review
  3. Article
  4. Article
  5. Prosthetic Metals: Release, Metabolism and Toxicity.International journal of nanomedicine · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. The role of CaCell proliferation · 2021
    Review
  14. Role of KInternational journal of molecular sciences · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Li SunBone Program and Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Harry C Blair
Yuanzhen Peng
Neeha Zaidi
Olugbenga A Adebanjo
Xue Bin Wu
Xing Yao Wu
Jameel Iqbal
Solomon Epstein
Etsuko Abe
Baljit S Moonga
Mone Zaidi
University of Pittsburgh · USIcahn School of Medicine at Mount Sinai · US

Funding

Role of FSH in Osreoclast Formation and FunctionR01AG023176 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ZAIDI, MONE · 2003 to 2012
$4.4M
A Transtheoretical Model of AA-Related Behavior ChangeR01AA014197 · NIAAA · UNIVERSITY OF NEW MEXICO · PI TONIGAN, J. SCOTT · 2004 to 2008
$1.6M
The Role of NFATc1 and Calcineurin in Bone RemodelingR01DK070526 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ZAIDI, MONE · 2004 to 2007
$1.4M
PHYTOESTROGEN REGULATION OF BONE TURNOVERR01AR047700 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BLAIR, HARRY C. · 2000 to 2004
$1.0M
CALMODULIN AND OSTEOCLAST CONTROLR01AG012951 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BLAIR, HARRY C. · 1994 to 2003
$858k
NIAAA NIH HHS R01 AA014197NIAMS NIH HHS AR 47700NIAMS NIH HHS R01 AR047700NIA NIH HHS AG 12951NIA NIH HHS AG 23176NIA NIH HHS R01 AG012951NIA NIH HHS R01 AG023176NIA NIH HHS R01 AG 14197NIDDK NIH HHS DK 70526NIDDK NIH HHS R01 DK070526
6 · The paper itself

Abstract

Two of the most commonly used immunosuppressants, cyclosporine A and tacrolimus (FK506), inhibit the activity of a ubiquitously expressed Ca(2+)/calmodulin-sensitive phosphatase, calcineurin. Because both drugs also cause profound bone loss in humans and in animal models, we explored whether calcineurin played a role in regulating skeletal remodeling. We found that osteoblasts contained mRNA and protein for all isoforms of calcineurin A and B. TAT-assisted transduction of fusion protein TAT-calcineurin Aalpha into osteoblasts resulted in the enhanced expression of the osteoblast differentiation markers Runx-2, alkaline phosphatase, bone sialoprotein, and osteocalcin. This expression was associated with a dramatic enhancement of bone formation in intact calvarial cultures. Calcineurin Aalpha(-/-) mice displayed severe osteoporosis, markedly reduced mineral apposition rates, and attenuated colony formation in 10-day ex vivo stromal cell cultures. The latter was associated with significant reductions in Runx2, bone sialoprotein, and osteocalcin expression, paralleled by similar decreases in response to FK506. Together, the gain- and loss-of-function experiments indicate that calcineurin regulates bone formation through an effect on osteoblast differentiation.

Indexed as

AnimalsCalcineurinCalcineurin InhibitorsCell DifferentiationGene DeletionIsoenzymesMiceMice, KnockoutOsteoblastsOsteogenesisOsteoporosisTacrolimusCalcineurinCalcineurin InhibitorsIsoenzymesTacrolimus

Identifiers

PMID16286645
PMCPMC1288002
OpenAlexW2046051881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.